Ardelyx (United States)

company in Fremont, United States

ARDX Nasdaq ISIN US0396971071 SEC CIK 1437402 LEI 549300F542QR4SXHCY32
Follow Ardelyx (United States) Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $127.7M +15.7% vs same quarter last year
Net income −$737K +23.9% vs same quarter last year
EPS, diluted $0.00
Operating cash flow $2.2M +494.8% vs same quarter last year
Revenue by quarter
$116.1M
$74.1M
$97.7M
$110.3M
$125.2M
$94.5M
$120.9M
$127.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$407.3M−$62M
FY24$333.6M−$39M
FY23$124.5M−$66M
FY22$52.2M−$67M
FY21$10.1M−$158M
FY20$7.6M−$94.3M
FY19$5.3M−$94.9M
FY18$2.6M−$91.3M
FY17$42M−$64.3M
FY16-−$112.4M
FY15$24M−$29.6M
FY14$31.6M−$3.2M
FY13$28.9M−$6.6M
FY12$5.4M−$9.8M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−4000%−3000%−2000%−1000%0%1000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2590.3%−10.1%−15.2%
FY2484.8%−8.4%−11.7%
FY2385.7%−50.8%−53%
FY2292.1%−122.2%−128.5%
FY2190.1%−1528.6%−1564.8%
FY2098.1%−1199%−1245.7%
FY1988.6%−1728.1%−1797.8%
FY1882.1%−3488.6%−3502%
FY1780%−155%−153.2%
FY16---
FY15100%−122.3%−123.3%
FY14-−4.9%−10.2%
FY13-−9.9%−22.7%
FY12-−162.8%−180.9%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$44M
FY24−$45.8M
FY23−$90.1M
FY22−$70.1M
FY21−$154.4M
FY20−$81.8M
FY19−$76.8M
FY18−$70.6M
FY17−$67.5M
FY16−$97.4M
FY15−$75.3M
FY14$11.5M
FY13$1.5M
FY12$21.9M
FY11-
Returned to shareholdersDividends paid and shares bought back
$0$5K$10K$15K$20KFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23-
FY22-
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14$2K
FY13$2K
FY12$20K
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Ardelyx (United States)
  • Healthcare median
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearArdelyx (United States)Healthcare median
FY25−15.2%−30.6%
FY24−11.7%−47%
FY23−53%−58%
FY22−128.5%−80.4%
FY21−1564.8%−71.8%
FY20−1245.7%−62.2%
FY19−1797.8%−46.2%
FY18−3502%−49.6%
FY17−153.2%−45.9%
FY16-−36%
FY15−123.3%−37.8%
FY14−10.2%−35.5%
FY13−22.7%−37.1%
FY12−180.9%−29.1%
FY11-−27.9%